11th Circ. Asked To Revive Fraud Claims Over Chinese Pharma
Investors in a putative class action against Chinese drugmaker Jiangbo Pharmaceuticals Inc. argued Friday in Miami that the Eleventh Circuit should reverse a lower court's dismissal of their case against the...To view the full article, register now.
Already a subscriber? Click here to view full article